Miguel Coelho

9.9k total citations · 4 hit papers
103 papers, 5.3k citations indexed

About

Miguel Coelho is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Miguel Coelho has authored 103 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Neurology, 19 papers in Cellular and Molecular Neuroscience and 12 papers in Epidemiology. Recurrent topics in Miguel Coelho's work include Parkinson's Disease Mechanisms and Treatments (57 papers), Neurological disorders and treatments (49 papers) and Botulinum Toxin and Related Neurological Disorders (24 papers). Miguel Coelho is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (57 papers), Neurological disorders and treatments (49 papers) and Botulinum Toxin and Related Neurological Disorders (24 papers). Miguel Coelho collaborates with scholars based in Portugal, France and United Kingdom. Miguel Coelho's co-authors include Cristina Sampaio, Joaquim J. Ferreira, Susan H. Fox, Klaus Seppi, Regina Katzenschlager, Mário Miguel Rosa, Santiago Perez‐Lloret, Daniel Weintraub, Olivier Rascol and Shen‐Yang Lim and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Miguel Coelho

99 papers receiving 5.1k citations

Hit Papers

The Movement Disorder Society Evidence‐Based Medicine Rev... 2011 2026 2016 2021 2011 2018 2019 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
    2011 866 citations Miguel Coelho, Cristina Sampaio et al. Movement Disorders profile →
  2. International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
    2018 668 citations Miguel Coelho, Cristina Sampaio et al. Movement Disorders profile →
  3. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
    2019 647 citations Miguel Coelho, Cristina Sampaio et al. Movement Disorders profile →
  4. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
    2011 387 citations Miguel Coelho, Cristina Sampaio et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Coelho Portugal 33 4.0k 1.4k 706 688 586 103 5.3k
Maria Teresa Pellecchia Italy 42 3.5k 0.9× 1.1k 0.8× 867 1.2× 488 0.7× 515 0.9× 173 5.0k
Claudio Pacchetti Italy 41 3.4k 0.9× 1.1k 0.8× 995 1.4× 517 0.8× 420 0.7× 135 4.8k
Hubert H. Fernandez United States 43 4.6k 1.1× 1.5k 1.1× 622 0.9× 867 1.3× 303 0.5× 225 6.0k
Tanya Simuni United States 43 3.8k 1.0× 1.1k 0.8× 1.0k 1.4× 734 1.1× 503 0.9× 162 5.6k
Kapil D. Sethi United States 43 5.3k 1.3× 1.7k 1.2× 1.0k 1.5× 889 1.3× 511 0.9× 149 7.1k
Caroline Rick United Kingdom 25 4.4k 1.1× 1.9k 1.4× 1.2k 1.8× 814 1.2× 978 1.7× 54 6.5k
Mariangela Pierantozzi Italy 41 3.8k 1.0× 1.6k 1.2× 1.0k 1.5× 524 0.8× 698 1.2× 169 5.6k
Wolfgang H. Jost Germany 45 4.9k 1.2× 1.4k 1.0× 347 0.5× 713 1.0× 819 1.4× 337 7.3k
Elan D. Louis United States 49 4.1k 1.0× 1.5k 1.1× 909 1.3× 1.1k 1.6× 918 1.6× 135 6.9k
Radu Constantinescu Sweden 28 3.8k 1.0× 1.3k 0.9× 335 0.5× 574 0.8× 892 1.5× 60 5.0k

Countries citing papers authored by Miguel Coelho

Since Specialization
Citations

This map shows the geographic impact of Miguel Coelho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Coelho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Coelho more than expected).

Fields of papers citing papers by Miguel Coelho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Coelho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Coelho. The network helps show where Miguel Coelho may publish in the future.

Co-authorship network of co-authors of Miguel Coelho

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Coelho. A scholar is included among the top collaborators of Miguel Coelho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Coelho. Miguel Coelho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbosa, Raquel, Paulo Bastos, Patrícia Pita Lobo, et al.. (2025). Differential Effects of Levodopa and Stimulation on Post‐Surgery Freezing of Gait in Subthalamic Nucleus Deep Brain Stimulation Parkinson's Disease Patients: A Clinical and Kinematic Analysis. Movement Disorders Clinical Practice. 12(11). 1859–1872. 1 indexed citations
2.
Chendo, Inês, Margherita Fabbri, Catarina Godinho, et al.. (2022). High frequency of Depressive Disorders and Suicidal Phenomena in Late-Stage Parkinson´s Disease – A Cross-Sectional Study. Journal of Geriatric Psychiatry and Neurology. 36(4). 336–346. 1 indexed citations
3.
Fabbri, Margherita, et al.. (2022). Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities. Journal of Personalized Medicine. 12(5). 813–813. 8 indexed citations
4.
Antunes, Ana, Bárbara Gomes, Luís Campos, Miguel Coelho, & Sílvia Lopes. (2021). Emergency department and hospital utilisation and expenditures in the last year of life: retrospective chronic diseases cohort study. BMJ Supportive & Palliative Care. 14(e1). e466–e469. 1 indexed citations
5.
Chendo, Inês, Margherita Fabbri, Catarina Godinho, et al.. (2021). High frequency of psychosis in late-stage Parkinsońs disease. Clinical Parkinsonism & Related Disorders. 5. 100119–100119. 9 indexed citations
6.
Dionísio, Pedro A., Leonor Correia Guedes, Nilza Gonçalves, et al.. (2020). Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology. Biomolecules. 10(6). 945–945. 39 indexed citations
7.
Fabbri, Margherita, Miguel Coelho, Daisy Abreu, et al.. (2019). Dysphagia predicts poor outcome in late-stage Parkinson's disease. Parkinsonism & Related Disorders. 64. 73–81. 29 indexed citations
8.
Miranda, Hugo Vicente, Leonor Correia Guedes, Marcos António Gomes, et al.. (2017). Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease. Scientific Reports. 7(1). 85 indexed citations
9.
Fabbri, Margherita, Isabel Guimarães, Rita M. Cardoso, et al.. (2017). Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease. Frontiers in Neurology. 8. 432–432. 48 indexed citations
10.
Rodrigues, Filipe B., Daisy Abreu, Joana Damásio, et al.. (2017). Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort. Movement Disorders Clinical Practice. 4(5). 737–742. 55 indexed citations
11.
Reimão, Sofia, Patrícia Pita Lobo, Dulce Neutel, et al.. (2015). Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson’s disease. Journal of Parkinson s Disease. 5(3). 561–567. 13 indexed citations
12.
Reimão, Sofia, Patrícia Pita Lobo, Dulce Neutel, et al.. (2014). Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. European Journal of Neurology. 22(3). 540–546. 80 indexed citations
13.
Coelho, Miguel, M. J. Martí, Cristina Sampaio, et al.. (2014). Dementia and severity of parkinsonism determines the handicap of patients in late‐stage Parkinson's disease: the Barcelona−Lisbon cohort. European Journal of Neurology. 22(2). 305–312. 33 indexed citations
14.
Neutel, Dulce, Tiago Teodoro, Miguel Coelho, José Pimentel, & Luí­sa Albuquerque. (2014). Spinal cord astrocytoma mimicking multifocal myelitis. Journal of Spinal Cord Medicine. 37(4). 429–431. 1 indexed citations
15.
Lobo, Patrícia Pita, et al.. (2011). Myeloradiculopathy associated toSchistosoma mansoni. BMJ Case Reports. 2011. bcr1220103631–bcr1220103631. 3 indexed citations
16.
Rosa, Mário Miguel, et al.. (2010). Prescribing patterns of antiparkinsonian agents in Europe. Movement Disorders. 25(8). 1053–1060. 21 indexed citations
17.
Coelho, Miguel, Joaquim J. Ferreira, Mário Miguel Rosa, & Cristina Sampaio. (2008). Treatment options for non-motor symptoms in late-stage Parkinson's disease. Expert Opinion on Pharmacotherapy. 9(4). 523–535. 20 indexed citations
18.
Ferreira, Joaquim J., Luís Almeida, Luı́s Cunha, et al.. (2008). Effects of Nebicapone on Levodopa Pharmacokinetics, Catechol-O-methyltransferase Activity, and Motor Fluctuations in Patients with Parkinson Disease. Clinical Neuropharmacology. 31(1). 2–18. 26 indexed citations
19.
Costa, João, Ana A Borges, Cláudia C Espírito-Santo, et al.. (2003). Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews. CD004314–CD004314. 12 indexed citations
20.
Tolosa, Eduardo, Miguel Coelho, & Marisol Gallardo. (2003). DAT imaging in drug-induced and psychogenic parkinsonism. Movement Disorders. 18(S7). S28–S33. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Pellecchia Breakdown of academic impact, for papers by Claudio Pacchetti Breakdown of academic impact, for papers by Hubert H. Fernandez Breakdown of academic impact, for papers by Tanya Simuni Breakdown of academic impact, for papers by Kapil D. Sethi Breakdown of academic impact, for papers by Caroline Rick Breakdown of academic impact, for papers by Mariangela Pierantozzi Breakdown of academic impact, for papers by Wolfgang H. Jost Breakdown of academic impact, for papers by Elan D. Louis Breakdown of academic impact, for papers by Radu Constantinescu
Rankless by CCL
2026